Catastrophic financial effect of replacing informal care with formal care: a study based on haematological neoplasms.


Journal

The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 13 12 2017
accepted: 10 08 2018
pubmed: 20 8 2018
medline: 23 8 2019
entrez: 20 8 2018
Statut: ppublish

Résumé

Informal care is a substantial source of support for people with cancer. However, various studies have predicted its disappearance in the near future. The aim of this study is to analyse the catastrophic effect resulting from the substitution of informal care with formal care in patients with blood cancer throughout the different stages of treatment. A total of 139 haematological neoplasm patients who underwent stem cell transplantation in Spain, completed a longitudinal questionnaire according to the three phases of treatment between 2012 and 2013. The economic value of informal care was estimated using proxy good, opportunity cost, and contingent valuation methods. Catastrophic health expenditure measures with thresholds ranging from 5 to 100% were used to value the financial burden derived from substitution. A total of 88.5% of patients reported having received informal care. In 85.37%, 80.49%, and 33.33% of households, more than 40% of their monthly income would have to be devoted to the replacement with formal care, with monthly amounts of €2105.22, €1790.86, and €1221.94 added to the 40% in the short, medium, and long-term, respectively (proxy good method, value = 9 €/h). Informal caregivers are a structural support for patients with blood cancer, assuming significant care time and societal costs. The substitution of informal care with formal care would be financially unaffordable by the families of people with blood cancer.

Identifiants

pubmed: 30121870
doi: 10.1007/s10198-018-0998-7
pii: 10.1007/s10198-018-0998-7
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Pagination

303-316

Subventions

Organisme : Spanish State Programme of R+D+I
ID : ECO2017-83771-C3-1-R
Organisme : Spanish State Programme of R+D+I
ID : ECO2013-48217-C2-2-R

Références

Health Aff (Millwood). 1986 Winter;5(4):138-45
pubmed: 3102333
Health Policy. 2016 Aug;120(8):948-59
pubmed: 27421172
Acta Oncol. 2016;55(1):30-7
pubmed: 25833414
Asian Pac J Cancer Prev. 2014;15(6):2713-7
pubmed: 24761890
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 28417550
J Aging Health. 2008 Aug;20(5):483-503
pubmed: 18420838
Support Care Cancer. 2008 Nov;16(11):1243-54
pubmed: 18322708
J Clin Oncol. 2010 Feb 20;28(6):1011-6
pubmed: 20065176
Eur J Health Econ. 2012 Aug;13(4):461-90
pubmed: 21584815
Psychooncology. 2012 Mar;21(3):273-81
pubmed: 22383269
Salud Publica Mex. 2011;53 Suppl 2:s85-95
pubmed: 21877097
Support Care Cancer. 2014 Jun;22(6):1637-46
pubmed: 24496758
J Clin Oncol. 2001 Jul 1;19(13):3219-25
pubmed: 11432889
Pharmacoeconomics. 2017 Mar;35(3):331-345
pubmed: 27848219
Rev Esp Salud Publica. 2015 Apr;89(2):201-13
pubmed: 26121629
Health Serv Res. 2018 Aug;53 Suppl 1:3227-3244
pubmed: 28858372
Support Care Cancer. 2015 Mar;23(3):889-98
pubmed: 25337681
Int J Equity Health. 2015 Jan 20;14:8
pubmed: 25599715
Cancer. 2013 Jun 1;119 Suppl 11:2160-9
pubmed: 23695928
J Clin Oncol. 2011 Jun 1;29(16):2230-9
pubmed: 21464398
Pharmacoeconomics. 2008;26(4):269-80
pubmed: 18370563
J Natl Cancer Inst. 2016 Oct 20;109(2):
pubmed: 27754926
BMC Public Health. 2016 Sep 15;16:992
pubmed: 27633253
Gac Sanit. 2011 Dec;25 Suppl 2:85-92
pubmed: 22154344
Health Econ. 2003 Nov;12(11):921-34
pubmed: 14601155
Gac Sanit. 2018 Sep - Oct;32(5):411-417
pubmed: 28529098
Support Care Cancer. 2013 Dec;21(12):3461-9
pubmed: 23955026
Cancer. 2008 Jun 1;112(11 Suppl):2556-68
pubmed: 18428199
Int J Equity Health. 2013 May 30;12:38
pubmed: 23718769
Gac Sanit. 2017 Jan - Feb;31(1):23-29
pubmed: 27856017
Int J Technol Assess Health Care. 2007 Spring;23(2):223-31
pubmed: 17493308
BMC Health Serv Res. 2015 Jan 22;15:26
pubmed: 25608983
J Clin Oncol. 2016 Jan 20;34(3):259-67
pubmed: 26644532
Acta Oncol. 2015 Apr;54(4):454-62
pubmed: 25519708
Glob Public Health. 2017 Oct;12(10):1282-1296
pubmed: 27132656
Health Serv Res. 1986 Dec;21(5):617-34
pubmed: 3102403
Value Health. 2015 Sep;18(6):832-40
pubmed: 26409611
Global Health. 2014 Apr 03;10:21
pubmed: 24708831
Eur J Oncol Nurs. 2011 Dec;15(5):500-7
pubmed: 21306952
J Oncol Pract. 2013 Jul;9(4):197-202
pubmed: 23942921
Clin J Oncol Nurs. 2013 Oct;17(5):500-6
pubmed: 23956004
J Cancer Surviv. 2010 Sep;4(3):202-9
pubmed: 20401542
Oncologist. 2010;15(8):883-93
pubmed: 20667966
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 27271848
Future Oncol. 2014 Nov;10(14):2189-99
pubmed: 25471033
Eur J Cancer Care (Engl). 2013 Nov;22(6):797-806
pubmed: 23834290
J Korean Med Sci. 2016 Mar;31(3):336-44
pubmed: 26955233
Eur J Health Econ. 2004 Feb;5(1):36-45
pubmed: 15452763
Rev Esp Salud Publica. 2009 May-Jun;83(3):393-405
pubmed: 19701571
Health Policy. 2014 Mar;115(1):44-51
pubmed: 24210762
Orphanet J Rare Dis. 2016 Jun 06;11(1):74
pubmed: 27266878
Bull World Health Organ. 2016 Mar 1;94(3):193-200
pubmed: 26966330
Health Aff (Millwood). 2007 Jul-Aug;26(4):972-83
pubmed: 17630440
Lancet. 2003 Jul 12;362(9378):111-7
pubmed: 12867110
Int J Equity Health. 2016 Oct 13;15(1):169
pubmed: 27737663

Auteurs

Marta Ortega-Ortega (M)

Department of Applied Economics, Public Economics and Political Economy. School of Economics and Business, Complutense University of Madrid, Campus de Somosaguas s/n. 28.023, Pozuelo de Alarcón, Madrid, Spain.

Raúl Del Pozo-Rubio (R)

Department of Economic Analysis and Finance, Faculty of Social Sciences, University of Castilla-La Mancha, Avenida de los Alfares, 44, 16.071, Cuenca, Spain. raul.delpozo@uclm.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH